Viewing Study NCT00099866


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-05-20 @ 1:06 PM
Study NCT ID: NCT00099866
Status: COMPLETED
Last Update Posted: 2012-05-07
First Post: 2004-12-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None type 2 diabetes View
None vildagliptin View